GILD monthly performance report
Monthly GILD research: returns, drawdown, relative strength, seasonality, and key stats.
GILD monthly report
—
Key takeaways
- Gilead Sciences (GILD) closed August 2026 at $130.86, up 0.50% for the month and +18.66% over the trailing 12 months.
- Year-to-date, GILD is +6.62%, underperforming the S&P 500 which has returned +12.71% YTD.
- The stock is trading −0.98% versus its 200-day moving average ($132.15), a cautious technical signal.
- Over the past three years, GILD has underperformed the S&P 500 by −5.69%, with a relative strength index reading of 95.1.
- Win rate over the trailing 39 months stands at 56.4% — 22 positive months versus 17 negative months.
Gilead Sciences ended August 2026 at $130.86, posting a monthly return of +0.50%. The S&P 500 returned +2.88% over the same window, leaving relative performance at −2.38%.
The current quarter stands at +2.08% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −0.98% versus the 200-day moving average ($132.15).
Year-to-date, GILD is +6.62% against SPY +12.71%, a gap of −6.09%. The stock is currently −16.80% below its 52-week high, with maximum 3-year drawdown at −27.65%.
| Period | GILD | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.68% | −0.16% | −0.52% |
| 1 Week | −1.41% | +5.36% | −6.77% |
| 1 Month | +0.50% | +2.88% | −2.38% |
| 3 Months | −0.60% | +6.65% | −7.25% |
| 6 Months |